Product Information
PAXIL 10 MG TABLET is a brand product labeled by Apotex Corp., priced at $9.3841 per EA under NDC 60505451703. Its NADAC has been published 61 times since Jul 17, 2024.
FDA first approved this application on Dec 29, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the paroxetine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Apotex Corp.NDC
60505451703
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/9/2024
Active Ingredients
PAROXETINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020031FDA Approved
12/29/1992
TE Code
AB
On Market Since
3/11/2019
Pharmacological Classes
Price Statistics
The NADAC for PAXIL 10 MG TABLET has been published 61 times since Jul 17, 2024, and over the history we have for it it has risen 10.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.3841 per EA |
|---|---|
| All-time high | $9.3841 (Sep 10, 2025) |
| All-time low | $8.5332 (Jul 17, 2024) |
| 52-week high | $9.3841 |
| 52-week low | $9.3841 |
| Median price | $9.3841 |
| Average price | $9.2866 |
| Largest weekly change | +9.9% (Sep 4, 2024) |
| Weeks tracked | 61 |
| Tracking since | Jul 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
N/A
5Y
N/A
All
+10.0%
Last surveyed Sep 10, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PAXIL 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAXIL 10 MG TABLET, manufactured by Apotex Corp., is $9.3841 per EA (NDC 60505451703), effective Sep 10, 2025.
How has the price of PAXIL 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAXIL 10 MG TABLET has risen 10.0%. It has been tracked across 61 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for PAXIL 10 MG TABLET?
Since Jul 17, 2024, the NADAC for PAXIL 10 MG TABLET has ranged from a low of $8.5332 (Jul 17, 2024) to a high of $9.3841 (Sep 10, 2025), with a median of $9.3841 per EA.
Are there cheaper alternatives to PAXIL 10 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PAROXETINE HCL 10 MG TABLET, is $0.0621 per EA — about 99% below PAXIL 10 MG TABLET.
Who manufactures PAXIL 10 MG TABLET?
PAXIL 10 MG TABLET (NDC 60505451703) is labeled by Apotex Corp., and CMS classifies it as a brand product.